crisaborole

Overview

Crisaborole is a novel PDE-4 inhibitor used as a nonsteroidal topical medication for the treatment of mild-to-moderate atopic dermatitis (eczema). Crisaborole selectively inhibits PDE-4B which mainly leads to inflammation. Tumor necrosis factor alpha (TNFα), interleukin-12 (IL-12), IL-23 and other cytokines are also suppressed while crisaborole functioning.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Inflammation / Immunology | PDE4

Product Information

• Catalog No.: B0084-426762
• CAS No.: 906673-24-3
• Molecular Formula: C14H10BNO3
• Molecular Weight: 251.048
• Purity: 99%

Source

Original product source